Pharmagest Interactive

LSE:0R9T UK
Market Cap
$541.73 Million
€527.76 Million EUR
Market Cap Rank
#15677 Global
#307 in UK
Share Price
€35.30
Change (1 day)
-0.42%
52-Week Range
€32.90 - €53.20
All Time High
€107.72
About

Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare p… Read more

Pharmagest Interactive (0R9T) - Total Liabilities

Latest total liabilities as of June 2025: €171.66 Million EUR

Based on the latest financial reports, Pharmagest Interactive (0R9T) has total liabilities worth €171.66 Million EUR as of June 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Pharmagest Interactive - Total Liabilities Trend (2004–2024)

This chart illustrates how Pharmagest Interactive's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Pharmagest Interactive Competitors by Total Liabilities

The table below lists competitors of Pharmagest Interactive ranked by their total liabilities.

Company Country Total Liabilities
Jahen Household Products Co. Ltd.
SHE:300955
China CN¥1.04 Billion
Mi Technovation Berhad
PINK:MITNF
USA $37.73 Million
Misun Technology Co Ltd
SHE:301577
China CN¥326.73 Million
Alector Inc
NASDAQ:ALEC
USA $262.59 Million
Hemisphere Properties India Limited
NSE:HEMIPROP
India ₹7.32 Billion
Avacta Group Plc
PINK:AVCTF
USA $29.09 Million
FastPartner AB (publ)
ST:FPAR-A
Sweden Skr21.51 Billion
Xinjiang Xinxin Mining Industry Co. Ltd
F:33X1
Germany €3.68 Billion

Liability Composition Analysis (2004–2024)

This chart breaks down Pharmagest Interactive's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.29 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.75 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.42 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pharmagest Interactive's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pharmagest Interactive (2004–2024)

The table below shows the annual total liabilities of Pharmagest Interactive from 2004 to 2024.

Year Total Liabilities Change
2024-12-31 €157.32 Million -5.46%
2023-12-31 €166.42 Million +8.05%
2022-12-31 €154.01 Million -6.50%
2021-12-31 €164.72 Million +12.19%
2020-12-31 €146.82 Million +16.35%
2019-12-31 €126.19 Million +18.20%
2018-12-31 €106.76 Million +45.77%
2017-12-31 €73.24 Million +55.68%
2016-12-31 €47.05 Million +45.09%
2015-12-31 €32.42 Million +1.78%
2014-12-31 €31.86 Million -4.43%
2013-12-31 €33.34 Million -4.71%
2012-12-31 €34.98 Million +8.12%
2011-12-31 €32.36 Million -4.53%
2010-12-31 €33.89 Million -5.83%
2009-12-31 €35.99 Million -9.90%
2008-12-31 €39.95 Million +10.24%
2007-12-31 €36.23 Million -2.47%
2006-12-31 €37.15 Million +34.48%
2005-12-31 €27.63 Million +5.20%
2004-12-31 €26.26 Million --